Phase 1 Acute Graft Versus Host Disease Clinical Trials

5 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–5 of 5 trials

Recruiting

Phase 1

A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.

Acute Graft Versus Host Disease

Accro Bioscience (Suzhou) Limited24 enrolled1 locationNCT07070674

Recruiting

Phase 1Phase 2

First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)

Acute Graft Versus Host Disease

First Affiliated Hospital of Zhejiang University35 enrolled1 locationNCT07285889

Recruiting

Phase 1

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Acute Graft Versus Host DiseaseHematopoietic and Lymphoid System Neoplasm

City of Hope Medical Center18 enrolled1 locationNCT05443425

Recruiting

Phase 1

Universal CNK-UT Therapy for Refractory aGVHD

Acute Graft Versus Host Disease

First Affiliated Hospital of Zhejiang University23 enrolled2 locationsNCT06750133

Recruiting

Phase 1

A study to evaluate the effect of food on the pharmakokinetics and cardiac function in male and female healthy volunteers who have been administered cannibidiol.

Acute Graft Versus Host Disease

Kalytera Australia Pty Ltd32 enrolled1 locationACTRN12619000443190